SuRo Capital - 6% NT REDEEM 30/12/2026 USD 25 EBIT

SuRo Capital - 6% NT REDEEM 30/12/2026 USD 25 posts a EBIT of $160M as of March 2026. That compares with $-3.2T in the prior-year period — up 100.0% year over year. That is below the Finance sector average of $300B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, SuRo Capital - 6% NT REDEEM 30/12/2026 USD 25's EBIT was $-3.2T. The latest reading is $160M — a 100.0% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

For Finance stocks, a EBIT near $300B is typical. SuRo Capital - 6% NT REDEEM 30/12/2026 USD 25's $160M is lower that level. That is roughly 99.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of SuRo Capital - 6% NT REDEEM 30/12/2026 USD 25's financial statement story. At $160M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SSSSL's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $300B), and (3) consistency with growth and profitability. This page covers the first two; SuRo Capital - 6% NT REDEEM 30/12/2026 USD 25's other metric pages and overview cover the third.